Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.

Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation of trial results and hindered evaluation of potentially efficacious HIV prevention gels. Understanding the underlying reasons why women join trials and their barriers to product use can support identif...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Lori Miller, Neetha Morar, Saidi Kapiga, Gita Ramjee, Richard Hayes
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0244652

Similar Items

Participants as community-based peer educators: Impact on a clinical trial site in KwaZulu-Natal
by: Sarita Naidoo, et al.
Published: (2013-07-01)

Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
by: Lori Miller, et al.
Published: (2022-01-01)

Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.
by: Robert Pool, et al.
Published: (2010-07-01)

Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania
by: Soteli Selephina, et al.
Published: (2009-10-01)

Vaginal microbicides: An overview
by: Hany Abdel-Aleem
Published: (2011-03-01)

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
by: Annalene Nel, et al.
Published: (2016-01-01)

A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.
by: Robert Pool, et al.
Published: (2010-07-01)

Ethical considerations in implementing a biometric coenrolment prevention system in clinical trials in South Africa
by: Jayajothi Moodley, et al.
Published: (2016-05-01)

Microbicides 2008 conference: From discovery to advocacy
by: Tolley Elizabeth E, et al.
Published: (2008-08-01)

Pregnancy incidence and risk factors among women participating in vaginal microbicide trials for HIV prevention: systematic review and meta-analysis.
by: Alfred Musekiwa, et al.
Published: (2013-01-01)

The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
by: Saidi H Kapiga, et al.
Published: (2013-01-01)

Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?
by: Andrew Vallely, et al.
Published: (2010-05-01)

Phase III microbicide trial methodology: opinions of experienced expanded safety trial participants in South Africa
by: Janneke van de Wijgert, et al.
Published: (2005-11-01)

Microbicide trials for preventing HIV/AIDS in South Africa: Phase II trial participants' experiences and psychological needs
by: Annalie Pistorius, et al.
Published: (2004-08-01)

Sexual behaviour, changes in sexual behaviour and associated factors among women at high risk of HIV participating in feasibility studies for prevention trials in Tanzania.
by: Diana Faini, et al.
Published: (2020-01-01)

Vaginal microbicides: detecting toxicities <it>in vivo </it>that paradoxically increase pathogen transmission
by: Abusuwwa Raed, et al.
Published: (2006-06-01)

Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems
by: Letícia Mesquita, et al.
Published: (2019-03-01)

G2-S16 dendrimer microbicide does not interfere with the vaginal immune system
by: Alba Martín-Moreno, et al.
Published: (2019-05-01)

Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability.
by: Stéphane Verguet, et al.
Published: (2010-11-01)

Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.
by: Deirdre E O'Hanlon, et al.
Published: (2013-01-01)

Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
by: Herold Betsy C
Published: (2006-12-01)

Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge.
by: Ashley T Haase, et al.
Published: (2015-01-01)

Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli
by: Moench Thomas R, et al.
Published: (2010-05-01)

Quantitative assessment of microbicide-induced injury in the ovine vaginal epithelium using confocal microendoscopy
by: Vargas Gracie, et al.
Published: (2012-02-01)

Nonlinear dynamics model of HIV/AIDS: Assessing the impacts of condoms, vaginal microbicides, and optimized treatment
by: Reuben Iortyer Gweryina, et al.
Published: (2024-12-01)

Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
by: I. Rodríguez-Izquierdo, et al.
Published: (2022-03-01)

The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania
by: Lees Shelley, et al.
Published: (2007-07-01)

Toll-Like Receptors and Cytokines as Surrogate Biomarkers for Evaluating Vaginal Immune Response following Microbicide Administration
by: Sadhana M. Gupta, et al.
Published: (2008-01-01)

A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)
by: Seul Ki Choi, et al.
Published: (2023-12-01)

A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.
by: Jill L Schwartz, et al.
Published: (2011-01-01)

MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide.
by: Georgina C Morris, et al.
Published: (2014-01-01)

Live microbial microbicides for HIV
by: Lagenaur Laurel, et al.
Published: (2006-12-01)

Cohort effects on sexual behavior and risk of acquisition of sexually transmitted infections and HIV in a South African HIV prevention trial
by: Makandwe Nyirenda, et al.
Published: (2018-09-01)

Quality control and performance of HIV rapid tests in a microbicide clinical trial in rural KwaZulu-Natal.
by: Nina von Knorring, et al.
Published: (2012-01-01)

Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials.
by: Marla J Keller, et al.
Published: (2010-01-01)

A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035).
by: Jose A Bauermeister, et al.
Published: (2023-01-01)

A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.
by: Federica Crostarosa, et al.
Published: (2009-11-01)

Microbicides for topical immunoprevention of HIV infection
by: Yu. V. Zhernov, et al.
Published: (2019-05-01)

Microbicidal Activity of Hypothiocyanite against Pneumococcus
by: Edriss Yassine, et al.
Published: (2021-10-01)

The use of objective adherence measures targeting four placebo microbicide delivery forms in the Quatro Clinical Crossover Study
by: Terry A. Jacot, et al.
Published: (2021-10-01)